These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22392833)

  • 1. Liraglutide-induced acute kidney injury.
    Kaakeh Y; Kanjee S; Boone K; Sutton J
    Pharmacotherapy; 2012 Jan; 32(1):e7-11. PubMed ID: 22392833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute pancreatitis associated with liraglutide.
    Lee PH; Stockton MD; Franks AS
    Ann Pharmacother; 2011 Apr; 45(4):e22. PubMed ID: 21487080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofarabine-associated acute kidney injury and proteinuria.
    Kintzel PE; Visser JA; Campbell AD
    Pharmacotherapy; 2011 Sep; 31(9):923. PubMed ID: 21923594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
    Montanya E; Sesti G
    Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the long-term cost-effectiveness of liraglutide versus exenatide BID in patients with type 2 diabetes who fail to improve with oral antidiabetic agents.
    Valentine WJ; Palmer AJ; Lammert M; Langer J; Brändle M
    Clin Ther; 2011 Nov; 33(11):1698-712. PubMed ID: 22018679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
    Wychowski MK; Kouides PA
    Ann Pharmacother; 2012 Apr; 46(4):e10. PubMed ID: 22496474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists.
    Dubois-Laforgue D; Boutboul D; Lévy DJ; Joly D; Timsit J
    Diabetes Res Clin Pract; 2014 Mar; 103(3):e53-5. PubMed ID: 24447807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
    Boruah PK; Bolesta S; Shetty SM
    Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatitis: a potential complication of liraglutide?
    Franks AS; Lee PH; George CM
    Ann Pharmacother; 2012 Nov; 46(11):1547-53. PubMed ID: 23136352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide. Type 2 diabetes: more prudent to continue using exenatide.
    Prescrire Int; 2010 Jun; 19(107):109-12. PubMed ID: 20738033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].
    Jahn E; Sausele T
    Med Monatsschr Pharm; 2009 Nov; 32(11):402-7. PubMed ID: 19947303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide: from clinical trials to clinical practice.
    Gough SC
    Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():33-40. PubMed ID: 22405267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenatide BID and liraglutide QD treatment patterns among type 2 diabetes patients in Germany.
    Miller LA; Burudpakdee C; Zagar A; Bhosle M; Reaney M; Schabert VF; Bruhn D
    J Med Econ; 2012; 15(4):746-57. PubMed ID: 22443463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesiculopustular dermatosis: an uncommon side-effect of liraglutide?
    Besemer F; Verschoor AJ; Diamant M; Hoogma RP
    J Diabetes Complications; 2012; 26(5):458-9. PubMed ID: 22727533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline-associated acute renal failure.
    Bird ML; Vesta KS
    Ann Pharmacother; 2008 Dec; 42(12):1908-11. PubMed ID: 18984856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solar burn reactivation induced by methotrexate.
    DeVore KJ
    Pharmacotherapy; 2010 Apr; 30(4):123e-6e. PubMed ID: 20334462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury secondary to exposure to insecticides used for bedbug (Cimex lectularis) control.
    Bashir B; Sharma SG; Stein HD; Sirota RA; D'Agati VD
    Am J Kidney Dis; 2013 Nov; 62(5):974-7. PubMed ID: 23800651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
    Pelletier EM; Pawaskar M; Smith PJ; Best JH; Chapman RH
    J Med Econ; 2012; 15(6):1039-50. PubMed ID: 22533526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide: clinical pharmacology and considerations for therapy.
    Sisson EM
    Pharmacotherapy; 2011 Sep; 31(9):896-911. PubMed ID: 21923591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.